Back to Agendas
CDER Town Hall
Session Chair(s)
Nancy D. Smith, PhD
Adjunct Professor
Temple University, FDA Alumni, United States
One of the many DIA Annual Meeting program highlights is the CDER Town Hall where leaders from the US FDA’s Center for Drug Evaluation and Research will participate in this interactive offering where members of the audience may submit questions. Topics to be discussed will be determined by the interest of the audience.
Attendees are welcome to submit questions of interest to the panel by emailing annualmeetingprogram@diaglobal.org; subject line: CDER Town Hall Q/A
Learning Objective : Summarize key issues discussed by CDER; Identify regulatory hot topics.
Speaker(s)
Panelist
Thomas W. Abrams, MBA, RPh
Former FDA, United States
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
Panelist
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Panelist
Sandra Kweder, MD
Greenleaf Health/Elilquent, United States
Principal, Drug and Biological Products
Panelist
Christine Moore, PhD
Organon & Co., United States
Executive Director, Global External Advocacy and Standards
Panelist
Theresa Mullin, PhD
FDA, United States
Associate Center Director - Strategic Initiatives, CDER
Panelist
Robert J. Temple, MD
FDA, United States
Senior Advisor for Clinical Science, OCD and Immediate Office, OND, CDER
Have an account?